We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEX
1851
DELISTED
Emerald Holding
EEX
$46K ﹤0.01%
4,731
+1,104
+30% +$11.3K
HRI icon
1852
Herc Holdings
HRI
$5.61B
$46K ﹤0.01%
1,002
-58
-5% -$2.52K
MNRO icon
1853
Monro
MNRO
$398M
$46K ﹤0.01%
+576
New +$46.1K
MTZ icon
1854
MasTec
MTZ
$21.9B
$46K ﹤0.01%
702
-243
-26% -$14.2K
NVST icon
1855
Envista
NVST
$4.52B
$46K ﹤0.01%
+1,651
New +$46.1K
POWL icon
1856
Powell Industries
POWL
$7.71B
$46K ﹤0.01%
+3,507
New +$43.6K
VLY icon
1857
Valley National Bancorp
VLY
$8.04B
$46K ﹤0.01%
4,281
-2,853
-40% -$30.5K
TVTY
1858
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$46K ﹤0.01%
2,788
+2,168
+350% +$37.5K
KIN
1859
DELISTED
Kindred Biosciences, Inc.
KIN
$46K ﹤0.01%
+6,708
New +$49.2K
ASPS icon
1860
Altisource Portfolio Solutions
ASPS
$65.8M
$45K ﹤0.01%
+275
New +$45K
AUPH icon
1861
Aurinia Pharmaceuticals
AUPH
$2.11B
$45K ﹤0.01%
8,382
+7,234
+630% +$43.8K
DRH icon
1862
Diamondrock Hospitality Co
DRH
$2.56B
$45K ﹤0.01%
4,357
-4,307
-50% -$42.5K
ILPT
1863
Industrial Logistics Properties Trust
ILPT
$586M
$45K ﹤0.01%
+2,120
New +$45.2K
KALV
1864
DELISTED
KalVista Pharmaceuticals
KALV
$45K ﹤0.01%
3,877
+3,685
+1,919% +$59.5K
KURA icon
1865
Kura Oncology
KURA
$850M
$45K ﹤0.01%
2,969
-2,699
-48% -$48K
MCS icon
1866
Marcus Corp
MCS
$945M
$45K ﹤0.01%
1,208
-7,920
-87% -$273K
MOV icon
1867
Movado Group
MOV
$841M
$45K ﹤0.01%
1,811
+896
+98% +$22.2K
NHTC icon
1868
Natural Health Trends
NHTC
$14.8M
$45K ﹤0.01%
6,390
+495
+8% +$3.63K
POST icon
1869
Post Holdings
POST
$3.57B
$45K ﹤0.01%
645
-1,668
-72% -$114K
SVM
1870
Silvercorp Metals
SVM
$2.53B
$45K ﹤0.01%
11,558
+11,058
+2,212% +$39.6K
TTEK icon
1871
Tetra Tech
TTEK
$9.07B
$45K ﹤0.01%
+2,620
New +$42.8K
UBX
1872
DELISTED
Unity Biotechnology
UBX
$45K ﹤0.01%
+741
New +$52.4K
UE icon
1873
Urban Edge Properties
UE
$2.73B
$45K ﹤0.01%
2,263
-11,125
-83% -$198K
WSC icon
1874
WillScot Mobile Mini Holdings
WSC
$4.41B
$45K ﹤0.01%
2,857
+2,679
+1,505% +$40.1K
XPO icon
1875
XPO
XPO
$23.7B
$45K ﹤0.01%
1,822
-2,243
-55% -$51.9K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.